ArticleTherapeutic advances in gastroenterology2021

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

Carl Eriksson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.